Search for Clinical Trial Results
Adenoma, Pleomorphic - 47 Studies Found
Status | Study |
Completed |
Study Name: Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus Condition:
Date: 2001-10-11 Interventions:
|
Completed |
Study Name: Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors Condition:
Date: 2008-12-30 Interventions:
|
Recruiting |
Study Name: A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer Condition:
|
Recruiting |
Study Name: A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma Condition: Recurrent Endometrial Cancer Date: 2011-09-28 Interventions: Drug: Lapatinib and ixempra Ixabepilone 40 mg/m2 Lapatinib 250 mg |
Recruiting |
Study Name: Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer Condition:
|
Completed |
Study Name: Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors Condition:
|
Completed |
Study Name: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer Condition:
|
Completed |
Study Name: Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer Condition:
|
Recruiting |
Study Name: Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer Condition:
|
Recruiting |
Study Name: Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer Condition:
|